Cafepharma Today

December 12 2019 - Gilead’s Kite files for FDA approval of second CAR-T
Gilead’s Kite files for FDA approval of second CAR-T
Merck’s Keytruda gets win for triple-negative breast cancer
AZ receives Chinese approval for Imfinizi in NSCLC
The House votes on the Lower Drug Cost Now Act
*please scroll down for all the latest news*

Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
House passes drug pricing bill that pharma warned would bring 'nuclear winter'
Biopharma Dive
Thursday, December 12, 2019 - 5:37pm
tags:
drug pricing, Lower Drug Cost Now Act of 2019, legislation
In a key step for psychedelic research, magic mushroom compound clears first clinical safety hurdle
Endpoints
Thursday, December 12, 2019 - 5:35pm
tags:
antidepressants, COMPASS Pathways, psilocybin
Here's Why Assembly Biosciences Stock Is Soaring Today
Motley Fool
Thursday, December 12, 2019 - 5:28pm
tags:
Assembly Biosciences
When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance
RAPS.org
Thursday, December 12, 2019 - 5:27pm
tags:
FDA, cancer, oncology, pediatric cancer, pediatric
After Its Celgene Acquisition, Bristol-Myers Squibb's Future Looks Bright
Motley Fool
Thursday, December 12, 2019 - 5:25pm
tags:
Celgene, M&A, Bristol-Myers Squibb
It's official: New FDA Commissioner Hahn wins Senate confirmation
Fierce Pharma
Thursday, December 12, 2019 - 5:23pm
tags:
FDA, Stephen Hahn
Anthem Will Use Blockchain To Secure Medical Data For Its 40 Million Members In Three Years
Forbes
Thursday, December 12, 2019 - 5:22pm
tags:
Anthem, insurers, blockchain, data, cybersecurity
miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
Xconomy
Thursday, December 12, 2019 - 5:20pm
tags:
Miragen Therapeutics, pulmonary fibrosis, microRNA
Gilead's Kite files for FDA approval of second CAR-T therapy
Fierce Biotech
Thursday, December 12, 2019 - 11:27am
tags:
Gilead Sciences, KTE-X19, mantle cell lymphoma, CAR-T, Kite Pharma
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Thursday, December 12, 2019 - 11:12am
tags:
Merck, Ketyruda, Roche, Tecentriq, immuno-oncology, SABCS, triple-negative breast cancer
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
Pharmaforum
Thursday, December 12, 2019 - 11:10am
tags:
trade, biologics, drug pricing, regulatory, Canada, Mexico, China
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Xconomy
Thursday, December 12, 2019 - 11:02am
tags:
osteoporosis, Amgen, Europe, romosozumab, Evenity
FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug
Endpoints
Thursday, December 12, 2019 - 11:01am
tags:
FDA, Horizon Pharma, clinical trials, teprotumumab, thyroid eye disease
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
Xconomy
Thursday, December 12, 2019 - 10:59am
tags:
Aspen Neuro, Parkinson's Disease, stem cell therapy
Omega Funds Closes $438 Million Fund VI Aimed at the Life Sciences
BioSpace
Thursday, December 12, 2019 - 10:57am
tags:
Omega Funds, drug development
How The House Prescription Drug Plan Would Try To Lower Drug Prices
NPR
Thursday, December 12, 2019 - 10:56am
tags:
drug pricing, legislation, regulatory, Lower Drug Cost Now Act of 2019
AZ’s Imfinzi approved in early lung cancer in China
Pharmaforum
Thursday, December 12, 2019 - 10:55am
tags:
China, AstraZeneca, Imfinizi, non-small cell lung cancer
Value-based pricing for gene therapy? Maybe not ready for hemophilia
Biopharma Dive
Thursday, December 12, 2019 - 10:52am
tags:
Biomarin, hemophilia, hemophilia A, gene therapy, valoctocogene roxaparvovec, uniQure, hemophilia B, etranadez
4 Trends and Expectations for Drug Delivery in 2020
Medical Devices and Diagnostics Industry
Wednesday, December 11, 2019 - 10:49pm
tags:
drug delivery, devices, injectables, patients, data
15 pharma trends for 2020
Pharmaforum
Wednesday, December 11, 2019 - 10:33pm
tags:
RWE, real world evidence, digital pharma, patient centricity

Pages

Latest CP Wire Articles

[release] ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies
MedReps survey finds best companies to work for in 2020
[release] eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists
Karuna Therapeutics Files for $52 Million Offering
Biocept Files for $27 Million Offering
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Microbiome Report
TELA Bio Files for $69 Million IPO
Oyster Point Pharma Files for $85 Million IPO
Cabaletta Bio Files for $100 Million IPO

Latest Pharmagather Articles

Insurers + PBMs + Specialty Pharmacies + Providers: Will Vertical Consolidation Disrupt Drug Channels in 2020?
Drug Channels
Healthy China initiative emphasizes prevention
Elsevier
Arguments on Drug Pricing
In the Pipeline
PharmaPendium Team Collaborates with Pharma Companies on Drug-Drug Interaction Risk Calculator
Elsevier
The Hype Problem
In the Pipeline
Latest CMS Data: Drug Spending is Not Skyrocketing; Hospitals and Physicians Dominate Healthcare Costs
Drug Channels
sPCMA Business Forum 2020
Drug Channels
They Don’t Know
In the Pipeline
Are Field Sales Reps Getting a Bad Deal With Data?
pharmexec marketing
Pharma Jobs from Indeed

Pharma and Device News from NASDAQ

Toronto Innovation Acceleration Partners (TIAP) adds novel KRAS oncology project to its LAB150 portfolio
Thursday, December 12, 2019 - 7:00am
Veloxis Pharmaceuticals: Publication of Offer Document and Board Statement
Thursday, December 12, 2019 - 2:37am
Clarus Therapeutics Expands Executive Team in Preparation for Landmark Launch of JATENZO® (testosterone undecanoate) Capsules CIII
Wednesday, December 11, 2019 - 2:04pm
MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium
Wednesday, December 11, 2019 - 10:00am
ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa
Wednesday, December 11, 2019 - 7:00am
Madrigal Pharmaceuticals Announces Pricing of Secondary Offering
Tuesday, December 10, 2019 - 11:57pm
Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market
Tuesday, December 10, 2019 - 3:07pm
Flow Cytometry Market Worth $4.1 billion by 2027- Exclusive Report by Meticulous Research®
Tuesday, December 10, 2019 - 4:18am
Equillium Granted U.S. FDA Fast Track Designation for Itolizumab for the Treatment of Lupus Nephritis
Monday, December 9, 2019 - 4:10pm
MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual Meeting
Monday, December 9, 2019 - 3:05pm

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.